Cervical ripening using vaginal misoprostol before hysteroscopy: a double-blind randomized trial

Area of Science:

• Gynecology
• Pharmacology

Background:

• Hysteroscopy is a common gynecological procedure.
• Cervical dilation and associated pain can complicate hysteroscopy.

Purpose of the Study:

• To evaluate vaginal misoprostol's efficacy in reducing cervical dilation force and pain during hysteroscopy.

Main Methods:

• A randomized clinical trial involving 101 patients undergoing diagnostic hysteroscopy.
• Patients received either 400 mcg vaginal misoprostol or placebo 12-24 hours before the procedure.
• Cervical dilation force was measured with a tonometer, and pain with a visual analog scale.

Main Results:

• The misoprostol group required significantly less force for cervical dilation (5.0 vs 7.5 N, p=.02).
• Pain scores were significantly lower in the misoprostol group (42.1 vs 57.2, p=.004).
• Pelvic cramping was the primary reported side effect.

Conclusions:

• Vaginal misoprostol effectively reduces cervical dilation force and pain associated with hysteroscopy.
• The 400 mcg dose, administered 12-24 hours pre-procedure, offers a favorable risk-benefit profile with mild side effects.